603108 润达医疗
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)1.1776.69111.36511.40811.070
总资产报酬率 ROA (%)0.3521.8963.1493.4273.436
投入资产回报率 ROIC (%)0.4422.4384.0574.3154.257

边际利润分析
销售毛利率 (%)25.63726.58327.99026.99827.043
营业利润率 (%)4.1857.0717.7798.7799.107
息税前利润/营业总收入 (%)8.05710.62910.89412.10012.412
净利润/营业总收入 (%)2.3014.8396.2426.7527.127

收益指标分析
经营活动净收益/利润总额(%)97.57175.566103.84189.67385.806
价值变动净收益/利润总额(%)37.48035.39016.72017.66621.431
营业外收支净额/利润总额(%)0.9721.3350.4000.341-1.247

偿债能力分析
流动比率 (X)1.1911.2481.1541.2041.123
速动比率 (X)1.0081.0650.9640.9610.915
资产负债率 (%)61.66161.93465.49463.45059.905
带息债务/全部投入资本 (%)61.04060.04463.45261.096--
股东权益/带息债务 (%)61.05063.12155.09559.83665.691
股东权益/负债合计 (%)48.46348.29340.89245.41652.546
利息保障倍数 (X)2.1033.0703.5333.6763.632

营运能力分析
应收账款周转天数 (天)238.722225.516165.206136.5200.000
存货周转天数 (天)83.29780.21774.27673.9180.000